These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 15312873

  • 1. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH, Themistoclakis S, Raviele A, Bonso A, Rossillo A, Glatter KA, Yang Y, Scheinman MM.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):864-8. PubMed ID: 15312873
    [Abstract] [Full Text] [Related]

  • 2. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

  • 3. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
    Zhang HC, Guo JH, Fang Q, Zheng YA, Sun YM, Zhu WQ, Wan Z, Guo JX, Ge JB, Han SM.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):798-801. PubMed ID: 15949393
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
    Fragakis N, Papadopoulos N, Papanastasiou S, Kozirakis M, Maligkos G, Tsaritsaniotis E, Katsaris G.
    Pacing Clin Electrophysiol; 2005 Sep 30; 28(9):954-61. PubMed ID: 16176535
    [Abstract] [Full Text] [Related]

  • 5. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG, Perings SM, Zühlke C, Heidland UE, Perings C, Heintzen MP, Strauer BE.
    Intensive Care Med; 2002 Jul 30; 28(7):925-9. PubMed ID: 12122531
    [Abstract] [Full Text] [Related]

  • 6. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B, Straumann E, Bertel O.
    Int J Cardiol; 2005 Mar 18; 99(2):283-7. PubMed ID: 15749188
    [Abstract] [Full Text] [Related]

  • 7. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
    Steinwender C, Hönig S, Kypta A, Kammler J, Schmitt B, Leisch F, Hofmann R.
    Int J Cardiol; 2010 Jun 11; 141(3):260-5. PubMed ID: 19136164
    [Abstract] [Full Text] [Related]

  • 8. Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.
    Tercius AJ, Kluger J, Coleman CI, White CM.
    Pacing Clin Electrophysiol; 2007 Nov 11; 30(11):1331-5. PubMed ID: 17976094
    [Abstract] [Full Text] [Related]

  • 9. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ, Pfitzner P.
    Med Klin (Munich); 1996 Oct 15; 91(10):617-25. PubMed ID: 9019638
    [Abstract] [Full Text] [Related]

  • 10. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
    Kafkas NV, Patsilinakos SP, Mertzanos GA, Papageorgiou KI, Chaveles JI, Dagadaki OK, Kelesidis KM.
    Int J Cardiol; 2007 Jun 12; 118(3):321-5. PubMed ID: 17049640
    [Abstract] [Full Text] [Related]

  • 11. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
    Mountantonakis SE, Moutzouris DA, Tiu RV, Papaioannou GN, McPherson CA.
    Am J Emerg Med; 2006 Jul 12; 24(4):407-12. PubMed ID: 16787796
    [Abstract] [Full Text] [Related]

  • 12. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
    Patsilinakos S, Christou A, Kafkas N, Nikolaou N, Antonatos D, Katsanos S, Spanodimos S, Babalis D.
    Am J Cardiol; 2010 Sep 01; 106(5):673-6. PubMed ID: 20723644
    [Abstract] [Full Text] [Related]

  • 13. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
    Zhang N, Guo JH, Zhang HCh, Li XB, Zhang P, Xn Y.
    Int J Clin Pract; 2005 Dec 01; 59(12):1395-400. PubMed ID: 16351670
    [Abstract] [Full Text] [Related]

  • 14. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
    Glatter K, Yang Y, Chatterjee K, Modin G, Cheng J, Kayser S, Scheinman MM.
    Circulation; 2001 Jan 16; 103(2):253-7. PubMed ID: 11208685
    [Abstract] [Full Text] [Related]

  • 15. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.
    Hou Y, Fang PH, Liu J, Li XF, Hu JQ, Zhang S.
    Chin Med J (Engl); 2011 Mar 16; 124(5):710-3. PubMed ID: 21518563
    [Abstract] [Full Text] [Related]

  • 16. Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter.
    Morita N, Tanaka K, Yodogawa K, Hayashi M, Akutsu K, Yamamoto T, Satoh N, Kobayashi Y, Katoh T, Takano T.
    Pacing Clin Electrophysiol; 2007 Oct 16; 30(10):1242-53. PubMed ID: 17897127
    [Abstract] [Full Text] [Related]

  • 17. The safety and efficacy of ibutilide in children and in patients with congenital heart disease.
    Hoyer AW, Balaji S.
    Pacing Clin Electrophysiol; 2007 Aug 16; 30(8):1003-8. PubMed ID: 17669084
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
    Nair M, George LK, Koshy SK.
    J Am Board Fam Med; 2011 Aug 16; 24(1):86-92. PubMed ID: 21209348
    [Abstract] [Full Text] [Related]

  • 19. Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.
    Korantzopoulos P, Kolettis TM, Papathanasiou A, Naka KK, Kolios P, Leontaridis I, Draganigos A, Katsouras CS, Goudevenos JA.
    Heart; 2006 May 16; 92(5):631-4. PubMed ID: 16159973
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy and safety of ibutilide for conversion of atrial fibrillation/flutter].
    Yu Z, Xiang M, Ma C, Zhang S, Yang Y.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Mar 16; 42(2):212-6. PubMed ID: 23585009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.